← Open Payments lookup

VALENTINE OKOCHI: Open Payments

NPI 1447917943 · SUNNYSIDE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$585 in 19 payments from 10 companies in 2025. Trend: 2023 $137 · 2024 $36 · 2025 $585

Food & beverage: $585
CompanyPaymentsAmount
ABBVIE INC.1$126
Otsuka America Pharmaceutical, Inc.4$115
Janssen Pharmaceuticals, Inc3$98
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$97
Supernus Pharmaceuticals, Inc.1$38
Takeda Pharmaceuticals U.S.A., Inc.1$26
Medline Industries LP1$26
Neurocrine BioSciences, Inc.1$25
Xeris Pharmaceuticals, Inc.1$18
Bayer Healthcare Pharmaceuticals Inc.1$16

Products named: VRAYLAR, REXULTI, INVEGA SUSTENNA, CAPLYTA, Qelbree, TRINTELLIX, INGREZZA, RECORLEV.

Industry payments across WA — which companies pay providers there.